96 related articles for article (PubMed ID: 2164207)
1. [Immunocytochemical characterization of malignant pleural effusions of small cell bronchial cancer].
Guzman J; Kraft A; Bross KJ; Würtemberger G; Costabel U
Pneumologie; 1990 Feb; 44 Suppl 1():601-2. PubMed ID: 2164207
[TBL] [Abstract][Full Text] [Related]
2. Malignant pleural effusions due to small cell carcinoma of the lung. An immunocytochemical cell-surface analysis of lymphocytes and tumor cells.
Guzman J; Bross KJ; Costabel U
Acta Cytol; 1990; 34(4):497-501. PubMed ID: 2165344
[TBL] [Abstract][Full Text] [Related]
3. Immunocytochemical profile of malignant pleural effusions of small-cell lung cancer.
Tamiolakis D; Papadopoulos N; Cheva A; Lambropoulou M; Kotini A; Mikroulis D; Didilis V; Bitzikas N; Bougioukas G
Minerva Med; 2002 Dec; 93(6):479-83. PubMed ID: 12515971
[TBL] [Abstract][Full Text] [Related]
4. [Diagnostic value of the combined determination of carcinoembryonic antigen (CEA) in pleural effusion and serum with an enzyme immunoassay (EIA). Sensitivity, specificity and relation to tumor type].
Klech H; Rona G; Hutter C; Bayer PM; Kummer F
Wien Klin Wochenschr; 1986 Sep; 98(17):564-73. PubMed ID: 3020811
[TBL] [Abstract][Full Text] [Related]
5. Immunocytochemical staining of cells in 153 pleural effusions with a panel of monoclonal antibodies and lectins.
Abramenko IV; Gluzman DF; Sklyarenko LM; Pisnyachevskaya GV; Pinchouk VG
Anticancer Res; 1991; 11(2):629-34. PubMed ID: 1712178
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of CYFRA 21-1 in malignant and benign pleural effusions.
Toumbis M; Rasidakis A; Passalidou E; Kalomenidis J; Alchanatis M; Orphanidou D; Jordanoglou J
Anticancer Res; 1996; 16(4A):2101-4. PubMed ID: 8712750
[TBL] [Abstract][Full Text] [Related]
7. Immunocytochemical panel for distinguishing carcinoma cells from reactive mesothelial cells in pleural effusions.
Wu GP; Zhang SS; Fang CQ; Liu SL; Wang EH
Cytopathology; 2008 Aug; 19(4):212-7. PubMed ID: 18699986
[TBL] [Abstract][Full Text] [Related]
8. [Cytodiagnosis and marker determination in pleural effusion].
Odermatt BF; Pedio G
Schweiz Med Wochenschr; 1986 Dec; 116(49):1709-16. PubMed ID: 3544207
[TBL] [Abstract][Full Text] [Related]
9. hTERT gene amplification and clinical significance in pleural effusions of patients with lung cancer.
Cha N; Li XY; Zhao YJ; Wang EH; Wu GP
Clin Lung Cancer; 2012 Nov; 13(6):494-9. PubMed ID: 22464057
[TBL] [Abstract][Full Text] [Related]
10. Value of BCA-225 in the cytologic diagnosis of malignant effusions: an immunocytochemical study of 197 cases.
Loy TS; Diaz-Arias AA; Bickel JT
Mod Pathol; 1990 May; 3(3):294-7. PubMed ID: 2194212
[TBL] [Abstract][Full Text] [Related]
11. The value of the immunoperoxidase slide assay in the diagnosis of malignant pleural effusions in breast cancer.
Guzman J; Costabel U; Bross KJ; Wiehle U; Grunert F; Schaefer HE
Acta Cytol; 1988; 32(2):188-92. PubMed ID: 3279712
[TBL] [Abstract][Full Text] [Related]
12. Mammaglobin and CRxA-01 in pleural effusion cytology: potential utility of distinguishing metastatic breast carcinomas from other cytokeratin 7-positive/cytokeratin 20-negative carcinomas.
Ciampa A; Fanger G; Khan A; Rock KL; Xu B
Cancer; 2004 Dec; 102(6):368-72. PubMed ID: 15558786
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of seven tumour markers in pleural fluid for the diagnosis of malignant effusions.
Miédougé M; Rouzaud P; Salama G; Pujazon MC; Vincent C; Mauduyt MA; Reyre J; Carles P; Serre G
Br J Cancer; 1999 Nov; 81(6):1059-65. PubMed ID: 10576665
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological analysis of lung cancer resembling malignant pleural mesothelioma.
Kobashi Y; Matsushima T; Irei T
Respirology; 2005 Nov; 10(5):660-5. PubMed ID: 16268922
[TBL] [Abstract][Full Text] [Related]
15. Local immunotherapy with interferon-alpha in metastatic pleural and peritoneal effusions: correlation with immunologic parameters.
Stathopoulos GP; Baxevanis CN; Papadopoulos NG; Zarkadis IK; Papacostas P; Michailakis E; Tsiatas ML; Papamichail M
Anticancer Res; 1996; 16(6B):3855-60. PubMed ID: 9042270
[TBL] [Abstract][Full Text] [Related]
16. Positive effusion cytology as the initial presentation of malignancy.
Monte SA; Ehya H; Lang WR
Acta Cytol; 1987; 31(4):448-52. PubMed ID: 3604540
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic significance of cancer antigen 125, pancreatic oncofetal antigen, and carcinoembryonic antigen in malignant and tuberculous pleural effusions.
Niwa Y; Shimokata K
Jpn J Clin Oncol; 1986 Mar; 16(1):3-8. PubMed ID: 3009919
[TBL] [Abstract][Full Text] [Related]
18. Sensitive detection of small cell lung carcinoma cells by reverse transcriptase-polymerase chain reaction for prepro-gastrin-releasing peptide mRNA.
Saito T; Kobayashi M; Harada R; Uemura Y; Taguchi H
Cancer; 2003 May; 97(10):2504-11. PubMed ID: 12733150
[TBL] [Abstract][Full Text] [Related]
19. [Cytological exam of the pleural fluid in the diagnosis of neoplastic pleuritis. Cases contribution].
Vignale L; Galli G; Rossi PC; Parentini GC
Minerva Med; 1990 Jun; 81(6):455-9. PubMed ID: 2359501
[TBL] [Abstract][Full Text] [Related]
20. The unique cytologic picture of oat cell carcinoma in effusions.
Salhadin A; Nasiell M; Nasiell K; Silfverswärd C; Hjerpe A; Wadäs AM; Enstad I
Acta Cytol; 1976; 20(4):298-302. PubMed ID: 183433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
